Tenormin

A bioequivalence study of two oral formulations of 100 mg atenolol was carried out in 24 healthy volunteers following a single… (More)

BACKGROUND Atenolol is a cardioselective beta-blocker. Tenolol is a new formulation of atenolol, with bioequivalence to the… (More)

The purpose of this study was to describe the pharmacokinetics of and heart rate and blood pressure responses to (S)-atenolol… (More)

Nine hundred and thirty-nine patients with moderate to severe hypertension, observed for up to 10 years, were found to benefit… (More)

Atenolol, 50 mg, b.i.d., and propranolol, 80 mg b.i.d.,. were given to 28 patients with a presumed diagnosis of migraine, in a… (More)

 

1. The disposition and metabolism of 1-(4-carbamoyl[14C]methylphenoxy)-3-isopropylaminopan-2-ol (atenolol, Tenormin) has been… (More)

Atenolol (Tenormin or I.C.I. 66082) is a new beta-adrenergic blocking drug, unique in being cardio-selective and in having no… (More)

Two identical studies, one comparing the effect of single doses of a new beta-adrenoceptor blocker, atenolol (Tenormin) (50 mg… (More)

In 11 patients with severe angina pectoris a new beta-blocking drug, atenolol (Tenormin; I.C.I.66082), was found in a double… (More)